GlassScriptPhysician profile
Sarah Younger
NPI 1881630291
$11,317.85
in general payments reported to CMS, 2019-2025
39 companies · $790 in 2025
The $790 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $536 · 2021: $709 · 2022: $533 · 2023: $7,510 · 2024: $1,006 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,336 · Food and Beverage: $3,170 · Travel and Lodging: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,336.00 |
| Food and Beverage | $3,170.11 |
| Travel and Lodging | $1,798.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $6,580.02 | 2021-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novo Nordisk INC | $730.50 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $631.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $576.15 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $475.61 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $265.19 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $260.09 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.29 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $187.62 | 2020-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $185.65 | 2019-2025 | Xarelto, Spravato |
| Glaxosmithkline, LLC. | $181.57 | 2019-2025 | Shingrix, Arexvy |
| Insightec,INC | $123.21 | 2023 | Exablate |
| Amarin Pharma, INC. | $114.31 | 2019-2021 | |
| Exact Sciences Corporation | $101.06 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $59.31 | 2019-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Younger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.